These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Modulation of rapid plasminogen activator inhibitor in plasma by stanozolol.
    Author: Verheijen JH, Rijken DC, Chang GT, Preston FE, Kluft C.
    Journal: Thromb Haemost; 1984 Jul 29; 51(3):396-7. PubMed ID: 6437007.
    Abstract:
    Fibrinolytic activity in plasma euglobulin fractions can be increased by oral administration of stanozolol. This increase is not caused by increased synthesis or release of tissue-type plasminogen activator. A decreased level of fast acting t-PA inhibition is very probably the cause of the higher activity. These results suggest that this inhibition has a regulatory role on fibrinolysis in vivo.
    [Abstract] [Full Text] [Related] [New Search]